Supported by

Issue 44

March 2022

PERTINENT UPDATES

Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data.

Dawwas GK, Leonard CE, Lewis JD, Cuker A.
Ann Intern Med. 2022 Jan;175(1):20-28.
doi: 10.7326/M21-0717. Epub 2021 Dec 7.
PMID: 34871048.

Utilization of EKOS in Patients With Pulmonary Embolism.

Robles KE, Armbruster AL, Austin SE, Baker JN.
Innovations (Phila). 2022 Jan 27:15569845211057882.
doi: 10.1177/15569845211057882. Online ahead of print.
PMID: 35084255

Chronic thromboembolic pulmonary hypertension: a review of risk factors, management and current challenges.

Cannon JE, Jenkins DP, Hoole SP.
Expert Rev Cardiovasc Ther. 2022 Jan 26.
doi: 10.1080/14779072.2022.2034499. Online ahead of print.
PMID: 35081846

Clinical Implications of Body Composition and Exercise Capacity Following Pulmonary Endarterectomy.

Balki I, de Perrot M, Bavaghar-Zaeimi F, Nourouzpour S, Granton JT, Thenganatt J, McInnis M, McRae K, Donahoe L, Rozenberg D.
Ann Thorac Surg. 2022 Feb;113(2):444-451. 
doi: 10.1016/j.athoracsur.2021.01.066. Epub 2021 Mar 3.
PMID: 33667463

FROM OUR OWN

Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study.

Le Gal G, Kovacs MJ, Bertoletti L, Couturaud F, Dennie C, Hirsch AM, Huisman MV, Klok FA, Kraaijpoel N, Mallick R, Pecarskie A, Pena E, Phillips P, Pichon I, Ramsay T, Righini M, Rodger MA, Roy PM, Sanchez O, Schmidt J, Schulman S, Shivakumar S, Trinh-Duc A, Verdet R, Vinsonneau U, Wells P, Wu C, Yeo E, Carrier M; SSPE Investigators.Ann Intern Med. 2022 Jan;175(1):29-35.
doi: 10.7326/M21-2981. Epub 2021 Nov 23.
PMID: 34807722

Percutaneous mechanical thrombectomy in a real-world pulmonary embolism population: Interim results of the FLASH registry.

Toma C, Bunte MC, Cho KH, Jaber WA, Chambers J, Stegman B, Gondi S, Leung DA, Savin M, Khandhar S, Kado H, Koenig G, Weinberg M, Beasley RE, Roberts J, Angel W, Sarosi MG, Qaqi O, Veerina K, Brown MA, Pollak JS.
Catheter Cardiovasc Interv. 2022 Feb 3.
doi: 10.1002/ccd.30091. Online ahead of print.
PMID: 35114059

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.

Goldenberg NA, Kittelson JM, Abshire TC, Bonaca M, Casella JF, Dale RA, Halperin JL, Hamblin F, Kessler CM, Manco-Johnson MJ, Sidonio RF, Spyropoulos AC, Steg PG, Turpie AGG, Schulman S; Kids-DOTT Trial Investigators and the ATLAS Group. 
JAMA. 2022 Jan 11;327(2):129-137.
doi: 10.1001/jama.2021.23182.
PMID: 35015038; PMCID: PMC8753509.

COVID-19 and venous thromboembolism: A narrative review.

Angelini DE, Kaatz S, Rosovsky RP, Zon RL, Pillai S, Robertson WE, Elavalakanar P, Patell R, Khorana A.
Res Pract Thromb Haemost. 2022 Feb 15;6(2):e12666.
doi: 10.1002/rth2.12666.
PMID: 35224417; PMCID: PMC8847419.